Read + Share
Amedeo Smart
Independent Medical Education
Tun GSZ, Robinson K, Marshall L, Wright A, et al. The effect of infliximab dose escalation in inflammatory bowel disease patients with antibodies to infliximab. Eur J Gastroenterol Hepatol 2022;34:295-301.PMID: 35100176
Email
LinkedIn
Facebook
Twitter
Privacy Policy